Related Experiment Video
Updated: Jun 10, 2026

09:03
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Mannosylphosphodolichol synthase overexpression supports angiogenesis
Zhenbo Zhang1, Aditi Banerjee, Krishna Baksi
1Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico, USA.
Biocatalysis and Biotransformation
|July 20, 2010
Summary
Overexpressing Mannosylphosphodolichol synthase (DPMS) significantly boosts angiogenesis by increasing enzyme activity and cell proliferation. This highlights DPMS
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Mannosylphosphodolichol synthase (DPMS) is crucial for lipid-linked oligosaccharide (LLO) biosynthesis, a key step in N-linked protein glycosylation.
- Phosphorylation of DPMS enhances its catalytic activity, increasing LLO biosynthesis and protein N-glycosylation, which promotes angiogenesis.
Purpose of the Study:
- To investigate whether DPMS phosphorylation or overexpression drives angiogenesis.
- To determine the role of DPMS in regulating angiogenesis in capillary endothelial cells.
Main Methods:
- Quantitative reverse transcription PCR (QRT-PCR) to assess DPMS mRNA levels.
- Western blotting to quantify DPMS protein expression.
- Enzyme activity assays to measure DPMS catalytic function.
- Immunofluorescence microscopy to detect cell surface glycans.
- Cell proliferation and wound healing assays to evaluate angiogenesis.
Main Results:
- DPMS overexpression in capillary endothelial cells led to significantly higher DPMS mRNA and protein levels compared to controls.
- DPMS activity was approximately 108% higher in overexpressing cells.
- Increased expression of specific glycans (GlcNAc-beta-(1,4)-GlcNAc)1-4-beta-GlcNAc-NeuAc) was observed on the cell surface.
- DPMS overexpressing cells exhibited enhanced proliferation and accelerated wound healing.
Conclusions:
- DPMS overexpression, independent of phosphorylation, is sufficient to up-regulate angiogenesis.
- Increased DPMS activity and subsequent alterations in cell surface glycosylation contribute to enhanced endothelial cell proliferation and angiogenesis.
- DPMS is a key regulator of angiogenesis and a potential therapeutic target.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

